NSE filing, NSE: SHANTI. Summary written from the filing by ALFA Finder's alert engine.
Shanti Overseas (India) Ltd: key numbers
- Share price
- ₹5.70
- Market cap
- ₹6.33 Cr
- Revenue (annual)
- ₹4.32 Cr
- Net profit (annual)
- ₹-7.49 Cr
- P/E (TTM)
- -0.8×Sector 40.6×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shanti Overseas (India) Ltd
All →Shanti Overseas (India) Annual General Meeting
Shanti Overseas (India) Limited held its 15th Annual General Meeting. Key agenda items included financial statement adoption, director re-appointments, and subsidiary disinvestment approval.
Shanti Overseas (India) Merger & Restructuring
Shanti Overseas (India) Limited corrected clerical errors in its prior disclosure regarding the divestment of its material subsidiary, Shaan Agro Oils & Extractions Private Limited.
Shanti Overseas (India) Merger & Restructuring Worth ₹0 Cr
Shanti Overseas will divest its 100% stake in material subsidiary Shaan Agro Oils & Extractions for a total consideration of Rs. 4,560.
- Value
- ₹0.00 Cr
Shanti Overseas (India) Annual General Meeting
Shanti Overseas (India) Limited announced its 15th Annual General Meeting scheduled for September 30, 2026. The meeting will include proposals for director appointments and subsidiary disinvestment.
Shanti Overseas (India) Q1 FY27 Results: Net Profit ₹0 Cr
Shanti Overseas (India) Ltd reported net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Shanti Overseas (India) Board Meeting Date
Shanti Overseas (India) Limited scheduled a board meeting for August 14, 2026, to consider its unaudited financial results for the quarter ended June 2026.
Other management change announcements
All →Jivial Industries Management Change
Jivial Industries appointed Shivam Dineshbhai Sakariya as Additional Non-Executive Independent Director effective 5 November 2026. The NRC recommended the appointment.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Texmaco Rail & Engineering Management Change
Texmaco Rail & Engineering has re-appointed Mr. Udyavar Vittal Kamath as an Executive Director (WTD) with effect from 1 February 2027 for a 12-month term. The filing is a Regulation 30 management change disclosure.
- Execution
- 12 months from 1 February 2027
Windlas Biotech Management Change
Windlass Biotech reports Mr. Ashok Kumar Windlass ceased as Executive Director, resigning for succession planning, effective 5 November 2026. He moves to Founder President, and Hitesh Windlass becomes Managing Director.
Panasonic Energy India Company Management Change
Panasonic Energy India's Company Secretary and Compliance Officer, Srishti Jain, has resigned effective 30 November 2026. The board accepted the resignation at its 5 November 2026 meeting.
Varvee Global Management Change
Varvee Global's statutory auditor, Pankaj R Shah & Associates, resigned with immediate effect on 5 November 2026, citing preoccupancy with other audit assignments. The filing is a mandatory Regulation 30 auditor-resignation disclosure with no monetary value.